Real-World Outcomes of Gemcitabine, Cisplatin, and Nab-Paclitaxel Chemotherapy Regimen for Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis

BACKGROUND/AIMS: Advanced biliary tract cancer (BTC) is associated with poor survival. A recent phase II study of triplet combination chemotherapy, including gemcitabine, cisplatin, and nanoparticle albumin-bound (nab)-paclitaxel, has shown promising results. This study aimed to compare the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Kwangrok, Park, Jaewoo, Jung, Jae Hyup, Lee, Jong-Chan, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474496/
https://www.ncbi.nlm.nih.gov/pubmed/35000934
http://dx.doi.org/10.5009/gnl210346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474496/
https://www.ncbi.nlm.nih.gov/pubmed/35000934
http://dx.doi.org/10.5009/gnl210346

Ejemplares similares